Yang, Y

NFV, an HIV-1 protease inhibitor, induces growth arrest, reduced Akt signalling, apoptosis and docetaxel sensitisation in NSCLC cell lines. [electronic resource] - British journal of cancer Dec 2006 - 1653-62 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

0007-0920

10.1038/sj.bjc.6603435 doi


Adenocarcinoma--drug therapy
Animals
Antineoplastic Agents--therapeutic use
Apoptosis--drug effects
Carcinoma, Large Cell--drug therapy
Carcinoma, Non-Small-Cell Lung--drug therapy
Carcinoma, Squamous Cell--drug therapy
Cell Line, Tumor
Cell Proliferation--drug effects
Cyclin-Dependent Kinase Inhibitor p21--metabolism
Cyclin-Dependent Kinase Inhibitor p27
Docetaxel
Down-Regulation
Drug Combinations
Glycogen Synthase Kinases--metabolism
HIV Protease Inhibitors--pharmacology
Humans
Intracellular Signaling Peptides and Proteins--metabolism
Lung Neoplasms--drug therapy
Male
Mice
Mice, Inbred BALB C
Mice, Nude
Nelfinavir--pharmacology
Proto-Oncogene Proteins c-akt--antagonists & inhibitors
Proto-Oncogene Proteins c-bcl-2--metabolism
RNA, Small Interfering--pharmacology
Signal Transduction--drug effects
Taxoids--therapeutic use
Tumor Suppressor Protein p53--metabolism